Search

everythinglearnresearchcommunity

for

Search:↓

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

A man had an allergic reaction to minoxidil, which stopped after he discontinued use and started corticosteroids.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Current treatments for alopecia show no significant long-term benefits.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Smoking and certain health conditions like thyroid disease may make palmoplantar pustulosis harder to treat.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.